Zoladex 10.8 MG implant syrns
Ended Awarded
- Contract number
- SPE2DB25FJU43
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,564
Award facts
- Contract value 100% obligated
- $7,564.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,564.32 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a gonadotropin-releasing hormone agonist used in hormone therapy for certain cancers and endometriosis, reflecting the breadth of pharmaceutical specialties supported through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen's larger $999.999 billion DLA Troop Support Medical IDC (SPE2DX), which operates as a comprehensive global pharmaceutical support vehicle through December 2026. The parent contract enables AmerisourceBergen to supply a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability across multiple therapeutic domains and its successful track record in competitive federal procurement make it a key pharmaceutical distributor within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJU43?
SPE2DB25FJU43 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU43 worth?
The government has obligated $7,564 on SPE2DB25FJU43.
Is contract SPE2DB25FJU43 an order under another contract?
Yes. SPE2DB25FJU43 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU43 competed?
The extent of competition for SPE2DB25FJU43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award